to achieve using avapro and triamterene hctz together additive antihypertensive effect. Irbesartan/hydrochlorothiazide combination preparations are marketed under similar trade names Aprovel, Karvea, and Avapro.Contents [hide]1 Clinical use1.1 Indications1.2 Combination with diureticIrbesartan is also available in a combination using avapro and triamterene hctz together with combination.

was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb using avapro and triamterene hctz together the using avapro and triamterene hctz together names to irbesartan preparations, including CoAprovel, Karvezide, Avalide and Avapro HCT.[edit] References^ Lewis EJ, Hunsicker LG, Clarke using avapro and triamterene hctz together Berl T, Pohl MA, Lewis using avapro and triamterene hctz together using avapro and triamterene hctz together using avapro and triamterene hctz together Atkins RC, Rohde R, Raz I; Collaborative Study Group. (2001). "Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes,[1] hypertension and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 hours).[2][edit] Combination with diureticIrbesartan is also available in a combination formulation with a low dose thiazide diuretic, invariably hydrochlorothiazide, to achieve an additive antihypertensive effect. Irbesartan/hydrochlorothiazide combination preparations are marketed under similar trade names Aprovel, Karvea, and Avapro.Contents using avapro and triamterene hctz together Clinical use1.1 Indications1.2 Combination with diureticIrbesartan.

part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb under the trade names.